Cutaneous lupus may occur in infancy as transient lesions associated with and probably caused by maternal autoantibodies, or later in childhood, associated with the endogenous development of autoimmunity. In this review, clinical findings, diagnosis, management, and pathogenesis of neonatal lupus are discussed, and the management of cutaneous lupus in children is detailed. Lupus (2010) 19, 1112—1117.
Franco HL, Weston WL, Peebles C., Forstot SL, Phanuphak P.Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J Am Acad Dermatol1981; 4: 67-72.
2.
Lee LANeonatal lupus erythematosus. J Invest Dermatol1993; 100: 9S-13S.
3.
Lee LANeonatal lupus: clinical features, therapy, and pathogenesis. Curr Rheumatol Rep2001; 3: 391-395.
4.
Lee LA, Weston WLSpecial considerations concerning the cutaneous manifestations of rheumatic diseases in children. In: Sontheimer RD, Provost TT (eds), Cutaneous manifestations of rheumatic diseases. Baltimore , MD: Williams & Wilkins;1996. p. 323-344.
5.
Buyon JP, Hiebert R., Copel J., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol1998; 31: 1658-1666.
6.
Neiman AR, Lee LA, Weston WL, Buyon JPCutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr2000; 137: 674-680.
7.
Harmon CE, Lee LA, Huff JC, Norris DA, Weston WLThe frequency of antibodies to the SSA/Ro antigen in pregnancy sera . Arthritis Rheum1984; 28: S20 (abstract).
8.
Weston WL, Morelli JG, Lee LAThe clinical spectrum of anti-Ropositive cutaneous neonatal lupus erythematosus . J Am Acad Dermatol1999; 40: 675-681.
9.
Thornton CM, Eichenfield LF, Shinall EA, et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol1995; 33: 19-25.
10.
Satter EK, High WANon-bullous neutrophilic dermatosis within neonatal lupus erythematosus . J Cutan Pathol2007; 34: 958-960.
11.
David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LAClinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol1992; 99: 251-257.
12.
Lee LA, Gaither KK, Coulter SN, Norris DA, Harley JBPattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest1989; 83: 1556-1562.
13.
Taylor-Albert E., Reichlin M., Toews WH, Overholt ED, Lee LADelayed dilated cardiomyopathy as a manifestation of neonatal lupus: case reports, autoantibody analysis, and management. Pediatrics1997; 99: 733-735.
14.
Lee LA, Sokol RJ, Buyon JPHepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics2002; 109: E11.
15.
Watson R., Kang JE, May M., Hudak M., Kickler T., Provost TTThrombocytopenia in the neonatal lupus syndrome. Arch Dermatol1988; 124: 560-563.
16.
Prendiville JS, Cabral DA, Poskitt KJ, Au S., Sargent MACentral nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol2003 ; 20: 60-67.
17.
Boros CA, Spence D., Blaser S., Silverman EDHydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus . Arthritis Rheum2007; 57: 261-266.
18.
Martin V., Lee LA, Askanase AD, Katholi M., Buyon JPLong-term followup of children with neonatal lupus and their unaffected siblings . Arthritis Rheum2002; 46: 2377-2383.
19.
McCune AB, Weston WL, Lee LAMaternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med1987; 106: 518-523.
20.
Julkunen H. , Kurki P., Kaaja R., et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum1993; 36: 1588-1598.
21.
Alexander E. , Buyon JP, Provost TT, Guarnieri T.Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum1992; 35: 176-189.
22.
Garcia S., Nascimento JHM, Bonfa E., et al. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest1994; 93: 718-724.
Miranda-Carus ME, Boutjdir M., Tseng CE, DiDonato F., Chan EK, Buyon JPInduction of antibodies reactive with SSA/Ro-SSB/ La and development of congenital heart block in a murine model. J Immunol1998; 161: 5886-5892.
25.
Mazel JA, El-Sherif N., Buyon J., Boutjdir M.Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation1999; 99: 1914-1918.
26.
Suzuki H., Silverman ED, Wu X., et al. Effect of maternal autoantibodies on fetal cardiac conduction: an experimental murine model. Pediatr Res2005; 57: 557-562.
27.
Miranda-Carus ME, Askanase AD, Clancy RM, et al. Anti-SSA/ Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol2000; 165: 5345-5351.
28.
Clancy RM, Askanase AD, Kapur RP, et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block. J Immunol2002; 169: 2156-2163.
29.
Xue D., Shi H., Smith JD, et al. A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A2003; 100: 7503-7508.
30.
Provost TT, Watson R., Gammon WR, Radowsky M., Harley JB, Reichlin M.The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies . N Engl J Med1987; 316: 1135-1138.
31.
Sontheimer RD , Nguyen TQ, Buyon JP, et al. Clinical correlations of autoantibodies to a recombinant, hYRNA-binding form of human calreticulin . J Invest Dermatol1996; 106: 938 (abstract).
32.
Maddison PJ , Lee L., Reichlin M., et al. Anti-p57: a novel association with neonatal lupus. Clin Exp Immunol1995; 99: 42-48.
33.
Wang D., Buyon JP, Zhu W., Chan EKDefining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies. J Clin Invest1999; 104: 1265-1275.
34.
Miyagawa S. , Yanagi K., Yoshioka A., Kidoguchi K., Shirai T., Hayashi Y.Neonatal lupus erythematosus: maternal IgG antibodies bind to a recombinant NH2-terminal fusion protein encoded by human alpha-fodrin cDNA. J Invest Dermatol1998 ; 111: 1189-1192.
35.
Borda E., Sterin-Borda L.Autoantibodies against neonatal heart M1 muscarinic acetylcholine receptor in children with congenital heart block. J Autoimmun2001; 16: 143-150.
36.
Eftekhari P. , Roegel JC, Lezoualc’h F., Fischmeister R., Imbs JL, Hoebeke J.Induction of neonatal lupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor. Eur J Immunol2001; 31: 573-579.
37.
Buyon JP, Tseng CE, Di Donato F., Rashbaum W., Morris A., Chan EKCardiac expression of 52beta, an alternative transcript of the congenital heart block-associated 52-kd SS-A/Ro autoantigen, is maximal during fetal development. Arthritis Rheum1997; 40: 655-660.
38.
Fraire-Velazquez S., Herrera-Esparza R., Villalobos-Hurtado R., Avalos-Diaz E.Ontogeny of Ro hYRNAs in human heart. Scand J Rheumatol1999; 28: 100-105.
39.
Clancy RM, Neufing PJ, Zheng P., et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest2006; 116: 2413-2422.
40.
Lee LA, Frank MB, McCubbin VR, Reichlin M.The autoantibodies of neonatal lupus erythematosus. J Invest Dermatol1994; 102: 963-966.
41.
Bennion SD, Ferris C., Lieu TS, Reimer CB, Lee LAIgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. J Invest Dermatol1990; 95: 643-646.
42.
Lee LA, Alvarez K., Gross T., Harley JBThe recognition of human 60-kDa Ro ribonucleoprotein particles by antibodies associated with cutaneous lupus and neonatal lupus. J Invest Dermatol1996; 107: 225-228.
43.
Clancy RM, Backer CB, Yin X., et al. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis. Arthritis Rheum2004; 50: 2598-2603.
44.
Strandberg L., Winqvist O., Sonesson SE, et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol2008; 154: 30-37.
45.
Stea EA, Routsias JG, Clancy RM, Buyon JP, Moutsopoulos HM, Tzioufas AGAnti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum2006; 54: 2228-2234.
46.
Schaller J.Lupus in childhood. Clin Rheum Dis1982; 8: 219-228.
47.
Wananukul S. , Watana D., Pongprasit P.Cutaneous manifestations of childhood systemic lupus erythematosus. Pediatr Dermatol1998 ; 15: 342-346.
48.
George PM, Tunnessen Jr WWChildhood discoid lupus erythematosus. Arch Dermatol1993; 129: 613-617.
49.
Kettler AH, Bean SF, Duffy JO, Gammon WRSystemic lupus erythematosus presenting as a bullous eruption in a child. Arch Dermatol1988; 124: 1083-1087.
50.
Kuhn A., Richter-Hintz D., Oslislo C., Ruzicka T., Megahed M., Lehmann P.Lupus erythematosus tumidus-a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol2000; 136: 1033-1041.
Siamopoulou MA, Stefanou D., Drosos AASubacute cutaneous lupus-erythematosus in childhood. Clin Rheum1989; 8: 533-537.
53.
Taieb A., Hehunstre J-P., Goetz J., et al. Lupus erythematosus panniculitis with partial genetic deficiency of C2 and C4 in a child. Arch Dermatol1986 ; 122: 576-582.
54.
Meyer O., Hauptmann G., Tappeiner G., Ochs HD, Mascart-Lemone F.Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol1985; 62: 678-684.
55.
Manzi S., Urbach AH, McCune AB, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: Case report and review of the literature. Arthritis Rheum1991; 34: 101-105.
56.
Faurschou A. , Wulf HCThe relation between sun protection factor and amount of suncreen applied in vivo. Br J Dermatol2007; 156: 716-719.
57.
Rahman P., Gladman DD, Urowitz MBSmoking interferes with efficacy of antimalarial therapy in cutaneous lupus . J Rheumatol1998; 25: 1716-1719.
58.
Jewell ML, McCauliffe DPPatients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol2000; 42: 983-987.
